Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase | MicrobiomeTrials← Back to trialsNCT04195347
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2020-09-04Est. Completion: 2027-01
Enrollment target: 42 participants Locations- Novant Health Presbyterian Hemby Children's Hospital, Charlotte, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Other microbiome trials you might be interested in
Pancreatitis, Chronic; Diabetes; Transplant
Patients with severe chronic pancreatitis may be candidates to have their pancreas removed and their islets transplanted…
Minneapolis, United StatesCompleted Jul 1, 2023
Abdominal PainAcute PainAcute CholecystitisAcute AppendicitisAcute Pancreatitis
The goal of this non-inferiority observational study is to assess the diagnostic performance of low-dose CT with deep le…
Odense, DenmarkCompleted Jul 10, 2023
Familial Chylomicronemia
The purpose of AROAPOC3-3001 is to evaluate the efficacy and safety of ARO-APOC3 (plozasiran) in adult participants with…
Boca Raton, United StatesCompleted Apr 29, 2024